Explore

Food and Drug Administration

Education news and commentary, delivered right to your inbox.

Sign up for The 74 newsletter.
Pandemic

Congress Wants FDA to Explain Reported Delay in Moderna Toddler Vaccine Review

Asher Lehrer-Small
Pandemic

Pfizer Postpones Request that FDA Authorize Doses for Kids Under 5

Asher Lehrer-Small
Pandemic

Youth Ages 16 & 17 Now Eligible for Pfizer Booster Dose, FDA Says

Asher Lehrer-Small
Pandemic

FDA Panel Recommends Authorization of Pfizer Shots for Kids Ages 5 to 11

Asher Lehrer-Small
Pandemic

Pfizer Shot 91% Effective at Preventing COVID in Children Ages 5-11

Asher Lehrer-Small
Sign Up for The 74's Newsletter

Get the best of The 74’s education news, analysis and commentary in your inbox each weekday morning.